Searchable abstracts of presentations at key conferences in endocrinology

ea0066p38 | Diabetes 3 | BSPED2019

Remission rates, demographics and outcomes of paediatric patients with type 2 diabetes at a single centre: 2006–2018

Procter Elizabeth , Law James , Calvert Jennifer , Sachdev Pooja

Background: Incidence of type 2 diabetes (T2DM) is increasing in children and young people under the age of 18 years. This group has a higher risk of microvascular complications and a more adverse cardiovascular risk profile than those diagnosed later. Weight loss is essential for remission, but intensive input is often required to achieve this.Aims: 1. Describe the demographics of our T2DM population2. Look at our remission rates<...

ea0007oc14 | Development and growth | BES2004

The susceptibility of growth hormone missense variants to proteolytic degradation

Easter T , Millar D , Horan M , Newsway V , Fryklund L , Procter A , Cooper D , Scanlon M , Lewis M

Our previous studies of the gene responsible for the expression of pituitary GH (GH1 gene) have identified 13 novel missense mutations in 52 children with short stature and 154 controls, which occurred more frequently in patients than controls. These mutations result in expression of variant forms of GH with a single amino acid alteration that could lead to conformational changes within the protein, possibly resulting in cleavage sites hidden in wild-type GH becoming ex...

ea0003oc8 | Genetics: New Insights into Endocrine Disease | BES2002

Identification and characterization of a novel missense mutation in the growth hormone gene in a child with short stature

Lewis M , Procter A , Millar D , Horan M , Easter T , Newsway V , Fryklund L , Gregory J , Scanlon M , Cooper D

A child with short stature having height greater than 2 standard deviations below the mean for age and bone age delay of two years but with normal growth hormone secretion tests was identified. Since there was no known clinical cause of the short stature, it was decided to sequence both alleles of the patient's GH1 gene that encodes pituitary GH to determine whether there was a genetic defect responsible for the observed phenotype (with local ethical approval). A 3.2kb fragmen...

ea0007oc13 | Development and growth | BES2004

A novel GH variant (Ile179Met) exhibits a decreased ability to activate the ERK pathway

Lewis M , Horan M , Millar D , Easter T , Fryklund L , Gregory J , Valle C , Canete R , Ulied A , Procter A , Cooper D , Scanlon M

The pituitary-expressed growth hormone 1 gene was screened for mutation in a group of 74 Spanish children with familial short stature resulting in the identification of a novel Ile179Met missense mutation. Variant and wild-type GH were expressed in insect cells and functional studies were performed. The Ile179Met variant was shown to exhibit a similar degree of resistance to proteolysis as wild-type GH, indicating that the introduction of Met does not cause significant ...